Gene: PAX2
Official Full Name: paired box 2provided by HGNC
Gene Summary: PAX2 encodes paired box gene 2, one of many human homologues of the Drosophila melanogaster gene prd. The central feature of this transcription factor gene family is the conserved DNA-binding paired box domain. PAX2 is believed to be a target of transcriptional supression by the tumor suppressor gene WT1. Mutations within PAX2 have been shown to result in optic nerve colobomas and renal hypoplasia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06416 | PAX2 Knockout cell line (HCT 116) | Human | PAX2 | 1:2~1:4 | Negative | Online Inquiry |
PAX2 Gene Knockout Cell Lines are expertly developed biological tools, designed for researchers investigating the role of the PAX2 gene in various cellular processes and diseases. The generation of these knockout lines utilizes CRISPR/Cas9 gene-editing technology, effectively disabling the PAX2 gene to elucidate its function and involvement in critical signaling pathways, particularly those related to kidney development and certain cancers.
The mechanism of action involves the precise alteration of the genomic sequence encoding the PAX2 transcription factor, resulting in a complete loss of gene expression. This enables scientists to observe phenotypic changes and cellular responses in a controlled in vitro environment, shedding light on the contributions of PAX2 to tumorigenesis and organogenesis. By studying these knockout models, researchers can explore gene interactions and potential downstream effects, thereby improving our understanding of related pathologies.
The scientific importance of PAX2 Gene Knockout Cell Lines extends to various applications, including drug discovery, developmental biology, and regenerative medicine. They provide a critical resource for elucidating disease mechanisms, testing therapeutic interventions, and potentially identifying biomarkers for kidney-related disorders.
What sets our PAX2 Gene Knockout Cell Lines apart from alternatives is their high specificity and reproducibility, coupled with extensive validation data that demonstrates consistent results across multiple experiments. Our product undergoes rigorous quality control assessments, ensuring that researchers receive reliable and accurate models for their studies.
For researchers and clinicians, investing in PAX2 Gene Knockout Cell Lines accelerates the pace of scientific discovery and fosters innovation in therapeutic approaches. Our commitment to advancing biological research is underscored by our expertise in genetic modification technologies, ensuring that we provide top-tier products that enhance laboratory efficiency and outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.